Study of the Susceptibility of Clinical Isolates of Trichomonas Vaginalis to Metronidazole and Secnidazole

Overview

Journal Antimicrob Agents Chemother

Publisher American Society for Microbiology

Specialty Pharmacology

Date 2018 Feb 15

PMID 29439963

Citations 9

Authors

Arindam P Ghosh

Cheri Aycock

Jane R Schwebke

Affiliations

Soon will be listed here.

Abstract

Nitroimidazoles (metronidazole [MTZ] and tinidazole [TNZ]) are the only drugs recommended for treatment of infections. MTZ resistance occurs in 4% to 10% of cases of vaginal trichomoniasis (R. D. Kirkcaldy et al., Emerg Infect Dis 18:939-943, 2012; J. R. Schwebke and F. J. Barrientes, Antimicrob Agents Chemother 50:4209-4210, 2006) and TNZ resistance in 1% of cases (J. R. Schwebke and F. J. Barrientes, Antimicrob Agents Chemother 50:4209-4210, 2006). Emerging nitroimidazole-resistant trichomoniasis is concerning, because few alternatives to standard therapy exist. We assessed the prevalence of aerobic MTZ and secnidazole resistance among isolates collected in 2015 to 2016 from 100 women in Birmingham, Alabama, with positive cultures. Archived specimens were treated with secnidazole or MTZ (0.2 to 400 μg/ml) for 48 h, according to U.S. Centers for Disease Control and Prevention protocols. Ninety-six (96%) of the 100 clinical isolates tested demonstrated lower minimum lethal concentrations for secnidazole than for MTZ, suggesting that secnidazole has better activity than MTZ.

Citing Articles

Antimicrobial Resistance in Curable Sexually Transmitted Infections.

Giacani L, Bradshaw C, Muzny C, Graves K, Pasricha S, Jordan S Curr HIV/AIDS Rep. 2025; 22(1):14.

PMID: 39856345 DOI: 10.1007/s11904-025-00722-7.

Identification of 5-Nitroimidazole Resistance Targets.

Graves K, Reily C, Tiwari H, Srinivasasainagendra V, Secor W, Novak J Pathogens. 2023; 12(5).

PMID: 37242362 PMC: 10223654. DOI: 10.3390/pathogens12050692.

Prevalence and metronidazole resistance of among Japanese women in 2021.

Saito-Nakano Y, Umeki Y, Shimokawa C, Kobayashi K, Hashimoto K, Takada T IJID Reg. 2023; 7:130-135.

PMID: 37025347 PMC: 10070129. DOI: 10.1016/j.ijregi.2023.02.007.

Secnidazole: a treatment for trichomoniasis in adolescents and adults.

Muzny C, Van Gerwen O, Legendre D Expert Rev Anti Infect Ther. 2022; 20(8):1067-1076.

PMID: 35642509 PMC: 9844242. DOI: 10.1080/14787210.2022.2080656.

Secnidazole for Trichomoniasis in Women and Men.

Muzny C, Van Gerwen O Sex Med Rev. 2022; 10(2):255-262.

PMID: 35153156 PMC: 11019772. DOI: 10.1016/j.sxmr.2021.12.004.

References

Sutton M, Sternberg M, Koumans E, McQuillan G, Berman S, Markowitz L . The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004. Clin Infect Dis. 2007; 45(10):1319-26. DOI: 10.1086/522532. View

Nunez J, Gomez G . Low-dose secnidazole in the treatment of bacterial vaginosis. Int J Gynaecol Obstet. 2005; 88(3):281-5. DOI: 10.1016/j.ijgo.2004.11.028. View

Goldman L, Upcroft J, Workowski K, Rapkin A . Treatment of metronidazole-resistant Trichomonas vaginalis. Sex Health. 2009; 6(4):345-7. DOI: 10.1071/SH09064. View

Ahuja V, Dhar A, Bal C, Sharma M . Lansoprazole and secnidazole with clarithromycin, amoxycillin or pefloxacin in the eradication of Helicobacter pylori in a developing country. Aliment Pharmacol Ther. 1998; 12(6):551-5. DOI: 10.1046/j.1365-2036.1998.00338.x. View

Kissinger P, Adamski A . Trichomoniasis and HIV interactions: a review. Sex Transm Infect. 2013; 89(6):426-33. PMC: 3748151. DOI: 10.1136/sextrans-2012-051005. View

Chen M, Smith N, Fox E, Bingham J, Barlow D . Acetarsol pessaries in the treatment of metronidazole resistant Trichomonas vaginalis. Int J STD AIDS. 2002; 10(4):277-80. DOI: 10.1258/0956462991913943. View

Bosserman E, Helms D, Mosure D, Evan Secor W, Workowski K . Utility of antimicrobial susceptibility testing in Trichomonas vaginalis-infected women with clinical treatment failure. Sex Transm Dis. 2011; 38(10):983-7. DOI: 10.1097/OLQ.0b013e318224db39. View

Spence M, Harwell T, Davies M, Smith J . The minimum single oral metronidazole dose for treating trichomoniasis: a randomized, blinded study. Obstet Gynecol. 1997; 89(5 Pt 1):699-703. DOI: 10.1016/s0029-7844(97)81437-8. View

Sobel J, Nyirjesy P, Brown W . Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis. Clin Infect Dis. 2001; 33(8):1341-6. DOI: 10.1086/323034. View

10.

Nyirjesy P, Gilbert J, Mulcahy L . Resistant trichomoniasis: successful treatment with combination therapy. Sex Transm Dis. 2011; 38(10):962-3. DOI: 10.1097/OLQ.0b013e31822037e4. View

11.

Meingassner J, Heyworth P . Intestinal and urogenital flagellates. Antibiot Chemother (1971). 1981; 30:163-202. DOI: 10.1159/000398097. View

12.

Escobedo A, Canete R, Gonzalez M, Pareja A, Cimerman S, Almirall P . A randomized trial comparing mebendazole and secnidazole for the treatment of giardiasis. Ann Trop Med Parasitol. 2003; 97(5):499-504. DOI: 10.1179/000349803235002380. View

13.

Meingassner J, THURNER J . Strain of Trichomonas vaginalis resistant to metronidazole and other 5-nitroimidazoles. Antimicrob Agents Chemother. 1979; 15(2):254-7. PMC: 352642. DOI: 10.1128/AAC.15.2.254. View

14.

Gabriel G, Robertson E, Thin R . Single dose treatment of trichomoniasis. J Int Med Res. 1982; 10(2):129-30. DOI: 10.1177/030006058201000212. View

15.

Sena A, Miller W, Hobbs M, Schwebke J, Leone P, Swygard H . Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention. Clin Infect Dis. 2006; 44(1):13-22. DOI: 10.1086/511144. View

16.

Lossick J, Muller M, Gorrell T . In vitro drug susceptibility and doses of metronidazole required for cure in cases of refractory vaginal trichomoniasis. J Infect Dis. 1986; 153(5):948-55. DOI: 10.1093/infdis/153.5.948. View

17.

Allsworth J, Ratner J, Peipert J . Trichomoniasis and other sexually transmitted infections: results from the 2001-2004 National Health and Nutrition Examination Surveys. Sex Transm Dis. 2009; 36(12):738-44. PMC: 3117286. DOI: 10.1097/OLQ.0b013e3181b38a4b. View

18.

Harp D, Chowdhury I . Trichomoniasis: evaluation to execution. Eur J Obstet Gynecol Reprod Biol. 2011; 157(1):3-9. PMC: 4888369. DOI: 10.1016/j.ejogrb.2011.02.024. View

19.

Dan M, Sobel J . Failure of nitazoxanide to cure trichomoniasis in three women. Sex Transm Dis. 2007; 34(10):813-4. DOI: 10.1097/NMD.0b013e31802f5d9a. View

20.

Cudmore S, Delgaty K, Hayward-McClelland S, Petrin D, Garber G . Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis. Clin Microbiol Rev. 2004; 17(4):783-93, table of contents. PMC: 523556. DOI: 10.1128/CMR.17.4.783-793.2004. View